[
  {
    "id": "4c0f25daa5a229aa14a042a72e05b568",
    "title": "Complete Response Letter, Warning Letter and Shareholder Lawsuit Follow FDA Data Integrity Findings - JD Supra",
    "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQUGhhVWRtUDA3TEtVa0p6VElTMGE1eXNMcl9mMG1fY3FsdU1xSFdIODBGNWdMVlUtekUxUVFDbFVtZmpxVTF5WVdEblE0MTI0aFllWHJ2ZEM0UkhRcWNYRUdwbTlibUlJUzdPMmEwOUFRdWlTVXZGc2VMa0tvS3NaRXhRRHM4SGQwZGc?oc=5",
    "date": "2025-01-15T08:00:00.000Z",
    "dateFormatted": "15/01/2025",
    "source": "Google News - CRLs",
    "sourceCategory": "google",
    "sourceType": "crl",
    "summary": "Complete Response Letter, Warning Letter and Shareholder Lawsuit Follow FDA Data Integrity Findings  JD Supra",
    "company": "TBD",
    "types": [
      "warning_letter",
      "crl"
    ],
    "severity": 9,
    "priority": 3
  },
  {
    "id": "336012dc3d4ead797a5ed9b091ee24a9",
    "title": "Life Enthusiast Co-op",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/life-enthusiast-co-op-709315-08252025",
    "date": "2025-09-09T12:07:38.443Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "3421d55eb41bf747056503047b833183",
    "title": "Green Vitality dba Gr33n",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/green-vitality-dba-gr33n-710151-08252025",
    "date": "2025-09-09T12:07:38.442Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "52f4ab505441dcc29dba86b4a15142ea",
    "title": "ejuices.com",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ejuicescom-715645-08272025",
    "date": "2025-09-09T12:07:38.442Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "597135f53ab8bb3b4cc47e416c6857a0",
    "title": "HS GLOBAL DISTRIBUTION LLC, d/b/a O&Z WHOLESALE",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hs-global-distribution-llc-dba-oz-wholesale-715189-08282025",
    "date": "2025-09-09T12:07:38.442Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "1d6a27b48cff53d289cc33b5a3fae8fc",
    "title": "Amneal Pharmaceuticals, LLC",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amneal-pharmaceuticals-llc-709894-08272025",
    "date": "2025-09-09T12:07:38.442Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "2de29cd7c007a5025d1067c379c96887",
    "title": "My Holistic Honey c/o Shenzhen Qanhai Wanb Express Supply Chain Co., LTD",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/my-holistic-honey-co-shenzhen-qanhai-wanb-express-supply-chain-co-ltd-712052-08252025",
    "date": "2025-09-09T12:07:38.442Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "9fafeb8e6a7ef4a54cbdd6279a2ba1d4",
    "title": "Mel Honey US",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mel-honey-us-709535-08252025",
    "date": "2025-09-09T12:07:38.441Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "6ba4d152e5315f35e93c653927468867",
    "title": "Supply Center USA",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/supply-center-usa-710859-08252025",
    "date": "2025-09-09T12:07:38.441Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "299f46a6a945d7c5895b5eaf5bef48a0",
    "title": "chillzoneusa.com",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/chillzoneusacom-715556-08272025",
    "date": "2025-09-09T12:07:38.441Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "9b49fd47e8791688c320ed79b633917a",
    "title": "Wisconsin Pharmacal Company, LLC",
    "link": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wisconsin-pharmacal-company-llc-710329-08222025",
    "date": "2025-09-09T12:07:38.357Z",
    "dateFormatted": "09/09/2025",
    "source": "FDA Website Direct",
    "sourceCategory": "official",
    "sourceType": "warning_letter",
    "summary": "",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "e864a9f4c09176ac29d054d78947cef8",
    "title": "Staying Ahead of Enforcement: Executive Strategies To Prevent FDA Warning Letters - Med Device Online",
    "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOMlh0TnFnZkd6d2hLOEF3dUhfN1RKQmZQQ3J0UGl6SXdraUhiWXZYd2JZMVltRzRJRkZXUWQ0NU5ncE1UcUIyalVEcU1sQnpfQXdYZEdONzhySk9uMUJvakRGNmhtd0xYVGhMbXA4WnJmZ0RaWWF4ZE1IaVhQaEhiZmFrZEFUN0ZMcHdKdGxIdzdmY29qRHJpRXdLcGJ6VVFzWWgzd1J6VXdCWF9fVnZJdzdFZjZxVU8wMnRSellR?oc=5",
    "date": "2025-08-19T07:00:00.000Z",
    "dateFormatted": "19/08/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Staying Ahead of Enforcement: Executive Strategies To Prevent FDA Warning Letters  Med Device Online",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "30acd03bc9074176c587caab1506f5ca",
    "title": "The Warning Letter Wake-Up Call In 2025: What FDA Enforcement Is Really Telling Us - Med Device Online",
    "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPSWFHZV9SUHFlSUYzbS1VQVlBdURxT3dXR0k5QzlYOF9fM3VzOVZ1S250V290cE9FQ21Oa1liS2VWZkliVlVRYUJGcUhJZVFpOE1pWTNpVHZXLUg1TTJSaVU2QlBpWVpTUkZJQmVVN0NsSDBnbDNZLVJZRTRodDRWV1pLZ1E0WVZUNVhuQmdUTFpxd0QwSWd4Q3p2SWlXcm5XMWRMQzFKODBteDZMS0MtRWNLZFV3MXpW?oc=5",
    "date": "2025-08-12T07:00:00.000Z",
    "dateFormatted": "12/08/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "The Warning Letter Wake-Up Call In 2025: What FDA Enforcement Is Really Telling Us  Med Device Online",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "55eb8db3f36fb36af2e4de5c62e439ca",
    "title": "QuVa Pharma, Inc. Sugar Land, TX. Untitled Letter issued 06/18/2025",
    "link": "http://www.fda.gov/about-fda/fda-commissioner/quva-pharma-inc-sugar-land-tx-untitled-letter-issued-06182025",
    "date": "2025-08-11T13:13:34.000Z",
    "dateFormatted": "11/08/2025",
    "source": "FDA OII FOIA Electronic Reading Room",
    "sourceCategory": "official",
    "sourceType": "foia",
    "summary": "Task Description Request Please post to the OII FOIA Electronic Reading Room\nRecord Date 06/18/2025\nShort Title (70 char) QuVa Pharma, Inc. Sugar Land, TX. Untitled Letter issued 06/18/2025\nFEI Number 3012053582\nFirm Name QuVa Pharma, Inc\nRecord Type Untit\nState TX\nEstablishment Type Outsourcing Fac",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 1
  },
  {
    "id": "3fa554304859ed660b928225cf7873d7",
    "title": "How to Avoid FDA Warning Letters - Quality Digest",
    "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPUGFtcW8tNVkzQlRvell6cmZ6YU9IWlJYTkV4OHdINlcxTGRudlI1RnFLRWpXbjhYTU9fX25RbFd2UEp4dHRLcGQ2OXczNXE3eS1IWWhGMXVYRlZPS0xHOHZyVDYxQVdma19fSXBEYjhzSl9fSS1UR2dMLXJCREhReXlST2tBLTQxT2dDNGF4Z21SXy01UHZzN0R5Y05GcTI5a3Z3?oc=5",
    "date": "2025-06-17T07:00:00.000Z",
    "dateFormatted": "17/06/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "How to Avoid FDA Warning Letters  Quality Digest",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "f491c4346f1211eea7f5e896e70a6538",
    "title": "India's Aspen Biopharma Labs hit with FDA warning letter citing infrastructure, contamination and records problems - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPWjNlOVMwM2ZqWHVoYWFaRHFrYzd5bGlvNDZiTkYyTGNiaF9odWpQSGJ5RUIwNXI1RTUyRjhCZ2ZLeVVhLUdhRFppeE9XTm1RZjV5aWZTSjBrME9Mc210UXhTRzNFamlpWHYtdHFGWklpYm9qbklkdUFmSHF0NFN2RzhRaTY1T3JFNjlTSExackZHLXJMVVNYdl9zUmF1VldyS3dCNXJjVmpsZnJYZXA1a1N6dVdrZ3NUT1hGNnAxX1BzR0E?oc=5",
    "date": "2025-03-26T07:00:00.000Z",
    "dateFormatted": "26/03/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "India's Aspen Biopharma Labs hit with FDA warning letter citing infrastructure, contamination and records problems  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "c18b8c3e5d9276ca974851c56d92a50d",
    "title": "Lytgobi Untitled Letter - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1hbkNVUXl3dGVocUdqdjhfYlFRcnl1ODBPaUFsbTkwRjRaelRCWVJmWjhTcFd6T2FqemZFOS1reTMwb1lpN0RvOWVlai0tdGF1VGMw?oc=5",
    "date": "2025-03-21T07:00:00.000Z",
    "dateFormatted": "21/03/2025",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Lytgobi Untitled Letter  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "100f569412f86b86b8a236a25728384f",
    "title": "Dexcom receives warning letter based on FDA inspections of 2 plants - MedTech Dive",
    "link": "https://news.google.com/rss/articles/CBMidEFVX3lxTE1kZDFOS1BEdVY5c3h0X3NBWWxRdWhpUW1VTWRldDRSVXloWDAyUTdGUGZHcDZ0YlFhLVF6TF9vVndpaXVQR3gySWNKeXlFR0t3MG9mRU1uMzRQLXcxcngxbHkwZVZzV2FwekFnZ3JfeEdfeW1t?oc=5",
    "date": "2025-03-10T07:00:00.000Z",
    "dateFormatted": "10/03/2025",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "Dexcom receives warning letter based on FDA inspections of 2 plants  MedTech Dive",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "a3c26a41596d63c7d5b2e0b3ea8a0a7d",
    "title": "FDA hits pair of Indian API makers with warning letters, import alerts - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOcXZfQ0h3UUNRNHloVkowSHFBa1hyblNzMklrdGloN3NtakVTbDhlSjFVYXlxVzR2YmFVaVEyWWwzazQ4dU84RGxGd3hnYWxMVUFmNGNtbEM0T215cTEzd2NtSGZ6TE92b3ZmWGZyUlVkaHVQVktpRDBWWEx5R0lNNzh3ZWExX2NfR1o2OWw0dDlKZGx6bW9rd3BB?oc=5",
    "date": "2025-02-20T08:00:00.000Z",
    "dateFormatted": "20/02/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA hits pair of Indian API makers with warning letters, import alerts  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "804bbf12eff659be74e8474c6a1572a9",
    "title": "FDA slaps China-based API makers with separate warning letters outlining quality, testing shortfalls - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOckJqX1lIckFjTEQ1c3R3YWRlZnp4cVFfb2VtVVRoUC1SeTVMMGxFSGI3WEhXUUR1c0lVN0JHU2JKdGd0Zml6TjhXNy1wZ0hNME85d0cxaFZTemc5dXVTVS10RE9iN1FTUWprRWk0T0ZPRDR4Y3FIQWN5ZVM3Q2Q1dURDQzVTc3lhWVN1V0xxMTktRlhIM3VOSC1tdXNuRWR5UTh5TTBDb1VrOWx2bFpPOEV5TDRKRVVxSGJGWU5HSVJIajRt?oc=5",
    "date": "2025-02-11T08:00:00.000Z",
    "dateFormatted": "11/02/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA slaps China-based API makers with separate warning letters outlining quality, testing shortfalls  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "c9a2a45a10f66431321fe3dde90f060b",
    "title": "Hemady Untitled Letter - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5kdEExSnlhODhtc0RISHdGRFNuZjlyNHNRUVcweUFTNmltY1BzXzlmV05qZkU3S1kydWwzWWEtb3BQLTNVTDQ3VnB5aFlJZFNCeU5j?oc=5",
    "date": "2025-02-03T08:00:00.000Z",
    "dateFormatted": "03/02/2025",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Hemady Untitled Letter  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "3fcd9419252fdbf4a1ee137ae9e6510c",
    "title": "FDA warning letter reveals quality control, data integrity issues at Viatris plant in India - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNLVZtZVpSekVIb2VmQXJFQzJNamNBc3Z0ek83MkNMdHp3cHlhQjhuN0NIVlFNR1pxX25FR2xkNG01X0R4cjdINUNSZGZCd3llem5fWjl0S2xHVlRVaDdjYzFoVWRjYUFhRnc3alVPa193RWVNY3BjZFVzOVQwNDQ3VkVJNUVpSWNpcVNtT1A1cDZJakVqbm4xdWZtQnVJMUJETE4yM2VtRDJrdUVwWVRJQ3FNcHpCcTBteUtZYld6Vjk0Zw?oc=5",
    "date": "2025-01-06T08:00:00.000Z",
    "dateFormatted": "06/01/2025",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA warning letter reveals quality control, data integrity issues at Viatris plant in India  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "f03d382892f7413ff4614ad0b3e77fec",
    "title": "Viatris says India plant hit with FDA warning letter, import ban on 11 products - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQU1djX0V1eHMxNzQxTnRva3Zhaldfa2VxN2Z3ckFTS20waFh3TlhfQ1ZoMnlod3pKZzJRSzdZZFA3WUhlWjZ6UlBub01SRFNyc284aTJPN0xNS3locmtnamF3SkVSSEVLdTFXOFRLTF9sYkYzYlNlQkJoY3JNS3h4R0RfY2Y2ekhsVnc2eW4zQ19wRDBrN3MtYW5laWVNTXE2N2g1RHVzaE1aNkdWWXc?oc=5",
    "date": "2024-12-23T08:00:00.000Z",
    "dateFormatted": "23/12/2024",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Viatris says India plant hit with FDA warning letter, import ban on 11 products  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "ac380bda3e541116eeead63dd3db1da0",
    "title": "Krazati Untitled Letter Close-out - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9qUEFwVmhXTDdZVjZqSmRXU2NwNk45MlpFTF9JQzdGeEFwUU9CQXJXS05tMGxMcTRRUXhlNEc0Q1NpMmZKZGVMTTd2VndlcVlUc2Yw?oc=5",
    "date": "2024-12-11T08:00:00.000Z",
    "dateFormatted": "11/12/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Krazati Untitled Letter Close-out  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "deec9e2849613b9e3d17c7770b4338a5",
    "title": "Xeomin Untitled Letter - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE05S0tqazhsQklPTVhoYm1sVWVISXJoQXVjUFhETWlpTHZlMDR4R3pJNENqS2pCWmRtcmZRUlQ2MDRjbzk1dFR1Q1pDUVF0bDROeFo0?oc=5",
    "date": "2024-10-31T07:00:00.000Z",
    "dateFormatted": "31/10/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Xeomin Untitled Letter  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "545145cf3a72029e94a2a3a315da0919",
    "title": "Ubrelvy Untitled Letter Close-Out - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1KRUhxeG5PM0xrZHRsQnQxOFYyc0xQNWNUNVdmYjB4MzE3OGZHZEsxV1BxQjRYenptTnNleXpNYjUwelo0OUdQVk9ET1lQaWxCc2U0?oc=5",
    "date": "2024-10-30T07:00:00.000Z",
    "dateFormatted": "30/10/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Ubrelvy Untitled Letter Close-Out  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "6e582469d0a4e9139bc8e0bcc91dd657",
    "title": "Auvi-Q Untitled Letter Close-Out - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFA1NzJybGdldjd1UVhCcmlrOGtieU1wTEJPUlFtR2hYTHItQTJER3VXNXJjeDMtVWlUbGJHcXpoclZjV0pqcUVGSTRlVHI5R0JwazNB?oc=5",
    "date": "2024-09-27T07:00:00.000Z",
    "dateFormatted": "27/09/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Auvi-Q Untitled Letter Close-Out  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "3657b2be2c5f80ec51c6e863f386ba73",
    "title": "India's Zydus hit with warning letter as FDA flags glass contamination concerns and more - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPdUJnWl9iUGV2TDhjaVVORHBacVJMdlFzMUYxQ0tYWFJucGdxNE5hQU9NTWhYNUxub21pdEpzTF9CeWMwcldpd3h1a2tyanY4U1d1VVBJSTFpNVdiU3h2QUdTOTFGMVZVUmVLS2MtYjREMTZQdWtXV3hubkRwLTh4RjdEclpDcmhST01FQ0lleVhkdkw2NzJpc0FGUjNoenVfSVp6ZWdKbDhLRVhhSERNcE9oaw?oc=5",
    "date": "2024-09-11T07:00:00.000Z",
    "dateFormatted": "11/09/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "India's Zydus hit with warning letter as FDA flags glass contamination concerns and more  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "5ae7713da94f5a5c511860ae02d9a49a",
    "title": "FDA scrutiny of India’s Zydus results in warning letter - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPRXZjSjVUeGNPbmx2ZFRReEFsTXVwcF9UeU1janhzR1g1LWdaV0hMRGtoaVdUUVhUYldkdU1iekxmUU5Fd1NPeWZtOW1YVTlSWDh1NlRKZW1lb2N3YVNJMFZfRmZ5ajNmR3RfaDFYS3hNb2RsamNuMTZiRjFrQUJlMkNjVEJFNjVsWGNGMGpFMWp2RDhMRnc?oc=5",
    "date": "2024-09-03T07:00:00.000Z",
    "dateFormatted": "03/09/2024",
    "source": "Google News - Form 483",
    "sourceCategory": "google",
    "sourceType": "form_483",
    "summary": "FDA scrutiny of India’s Zydus results in warning letter  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "a2099fe622fd69599b1e58102014f8b4",
    "title": "Untitled Letter for Ubrelvy - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9yalJfd1ZKUUZ3cDNKbjZCdjlxb3kzZEgyWkVuLXM1UGY0UWRNS05fM2c3Zk1neXFCT1JuVDI5bllBNmJTakZSLWRvdGJQNzMyekI4?oc=5",
    "date": "2024-08-29T07:00:00.000Z",
    "dateFormatted": "29/08/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter for Ubrelvy  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "766219360550db842fc8d14fb08aac8b",
    "title": "Untitled Letter Krazati - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9lRk91bnpySjZ5ZnJEQWlzOHNxSm9uS01BVGVrVVFuZVJhTGhVYU1XYXpCU2VrclZCcnRMZm5rSWc0aktIMHZiZ1pLWDRqNWExbXdZ?oc=5",
    "date": "2024-08-01T07:00:00.000Z",
    "dateFormatted": "01/08/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Krazati  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "0dad9ede689e33b0fee1441e8ac20c25",
    "title": "Untitled Letter Auvi-Q - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE12dkF5Vl9GT0NTeFhHNHNmSV9hNDZCUnBkSWlzazRBWUtVcWs0LV9KUjVlTmwzdUxkX2R2a0xUOFhZWUhXdXRQRkpsZllrblRpRHV3?oc=5",
    "date": "2024-07-17T07:00:00.000Z",
    "dateFormatted": "17/07/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Auvi-Q  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "77f350078253cfcfe3c0b9b9befabcec",
    "title": "FDA Issues Warning Letters to 14 Online Retailers for Selling Unauthorized E-Cigarettes - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPdU1HSlNGLXo1dVlyX01Ub1Bqam9zNUcxc2lncU9oOWVOdkE2WXhRT3Z4eEhRQWRUU0RxUTBWbEpSUmtkRFpkRmo5LXRUT1BVRmtNRG1mOF9wSE5aLVNQYkxPNjhDYy03d2JEdlRfZ240ZkVLUGpHbHMxTEx1TEN5NEprRGFmZXIzX2p6eTZjSnU1LWE0SXEwVS15MXZHcWcxSnRTVHdnLUwyZ25SS2F0Q1hUaEFMcWRYSWJIYlR5NUlYaE1LT1N2WGNn?oc=5",
    "date": "2024-05-01T07:00:00.000Z",
    "dateFormatted": "01/05/2024",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "foia",
    "summary": "FDA Issues Warning Letters to 14 Online Retailers for Selling Unauthorized E-Cigarettes  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "8fcf8da078e35e14634e98d74d53f6c6",
    "title": "Import alerts, warning letters, drug recalls — why ‘pharmacy to the world’ is facing US FDA heat - ThePrint",
    "link": "https://news.google.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?oc=5",
    "date": "2024-04-23T07:00:00.000Z",
    "dateFormatted": "23/04/2024",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Import alerts, warning letters, drug recalls — why ‘pharmacy to the world’ is facing US FDA heat  ThePrint",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert",
      "recall"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "8cc0d770c7c1e0d640397efb12b7965a",
    "title": "Kisqali Untitled Letter Close-Out - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBDbGloT2FuMEozdXVocG9JVzJSNU5MR2E3TDdNN1R3YjE0S1JJNEZPNTR4UlBYY2p6aWJlcUxLYTlVNkJmYk5GVnJXYjlKX0M2MU53?oc=5",
    "date": "2024-03-15T07:00:00.000Z",
    "dateFormatted": "15/03/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Kisqali Untitled Letter Close-Out  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "1c33a026c08c4a968ce4fdca25d1b168",
    "title": "“Modernized” Food Manufacturing Enforcement: Trends in FDA Warning Letters - Food and Drug Law Institute (FDLI)",
    "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNdkRnbllwMnU3bWxjaWFEOEE3TV9hT19oQ2RlNkh0OTBoTzRiZG01clZsWVZfWXB1UHk2SjNOUkNUSEpBcnBJdlB1YjByU3VISlpnY1ZIYWJwMWk1bHJqeUdaQl9CeEE5Q052cXp1dkNPWGV0M09NQ0UxZjEweWtQanZZTGNVN1JtZi1SSDhHZGx3eGx6cGdOQWJhV1habmc2VUFR?oc=5",
    "date": "2024-03-08T08:00:00.000Z",
    "dateFormatted": "08/03/2024",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "“Modernized” Food Manufacturing Enforcement: Trends in FDA Warning Letters  Food and Drug Law Institute (FDLI)",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "95c2581b837b449275ef17edd0aaec1a",
    "title": "FDA unleashes multiple warning letters targeting insanitary manufacturing and online sales of unapproved Mounjaro, Ozempic - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPaV9WcHBaQ09CSjBXQlpDMmJyVm9SX0hhU205NlRNUlhNNzFYR3dMcWt3OTRoLUdYd1VlVGUxclNTV1B2N0o2djVIcllXQUgxWEhvZGNsckh2ejNoeFdab1E1c3F6ZXY4UU4zcXpyUTJZUTJFSGJTc3Z0OGlTWF82Y2tOMWFRZTlwaEdDOFJuaU5lRnY4SDRTelVaVnNTX1VrZ2xaU1lDd2tLS2t6RXZMeWxab1hiT0NzcW9JdDlYSm91TlZ5?oc=5",
    "date": "2024-02-14T08:00:00.000Z",
    "dateFormatted": "14/02/2024",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA unleashes multiple warning letters targeting insanitary manufacturing and online sales of unapproved Mounjaro, Ozempic  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "f1c56908033188b4446abe999792a971",
    "title": "Issuance of Untitled Letters - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNUEVmaE1sTE92WWpYLXUxSjE1ckxTR2NMbXVVNUNKS2lzTzVVOHpoVHJ5bHpIZDFMNjNLSjI1ZTQ0dDVRbVoydlE4LW96SnVFd2oxalJnM0VGYTdQOU1VR2lGX1k5TWo3UmVUa1JGZWt1bllOcVVRbjZuVFNrUzJZeWZDc0lIbE1VYUhHTTNaOTdYODd4b2JPTE5BQk52NFpKeWV3eW1acTU1Uk1zRUMwS3huR0E2TVlOV29URTl6SFlvbjdZRWJTR0haX1gtZFhRRTZaZndBa2FWQQ?oc=5",
    "date": "2024-02-07T08:00:00.000Z",
    "dateFormatted": "07/02/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Issuance of Untitled Letters  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "a0e0a6e7648bf62e68394ebe2d6e8f31",
    "title": "Untitled Letter Kisqali - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1ycENkVW5IWnZVcVNjZlJ5UGJXOXp1dTkyWUxaelNrXzJsTV9xUnFENDgzNExLcmdkQUV4QlVpMVIwWmVkcTVWbmRSNDU3WnBzc0hJ?oc=5",
    "date": "2024-01-18T08:00:00.000Z",
    "dateFormatted": "18/01/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Kisqali  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "6c046ba9c8b84ead4c3ab82bb77d772e",
    "title": "Untitled Letter Close-Out Phexxi | January 2024 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE81dnlKMHUxSko2dFcxZkp0U3c0azd4WGVfQy1Ecmo1aXFsSWJNSkJxUDdPeW9kd3FHV1hDMHl0RGtKaXgxa2xDdUJaMHlLd2p3Rkl3?oc=5",
    "date": "2024-01-05T08:00:00.000Z",
    "dateFormatted": "05/01/2024",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Close-Out Phexxi | January 2024  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "9afdefdea9dd933d938d2acfff5ece78",
    "title": "Untitled Letter Close-Out Rexulti - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBDNENpUzJxVnNRYUVhSkM1bFduRUNxXzlRVDlIY00wdWJtejJNbjBPRXlxVGcyN1YzMEhsaWhSc25xQl9oNTNKRlcxeFNQeWVHSnY4?oc=5",
    "date": "2023-12-20T08:00:00.000Z",
    "dateFormatted": "20/12/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Close-Out Rexulti  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "456f984d3db88aaf07482ef3cd145e7c",
    "title": "Intas Pharmaceuticals Hit with Another FDA Warning Letter, Put on Import Alert - BioSpace",
    "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPVVRudEJxcG1NTnJ1c2phcm5nQ3ZDcGRqXzVEeXdXclJMMy1Fendobk1WamNBNDFrZHZRQU9LNWFrRE92TWpUbEhvSS1FTWJCRW9YNFJnamZxN21xcF8tVmdkeFhuNjdyYnpUYkhSaTlTR1YzT3pWSEZnMkNuVWZvWTZsS1M0RkhnRjdjTlJiMG1WMjQ0bUxmMHUtQ05scHRONzVhaQ?oc=5",
    "date": "2023-11-30T08:00:00.000Z",
    "dateFormatted": "30/11/2023",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Intas Pharmaceuticals Hit with Another FDA Warning Letter, Put on Import Alert  BioSpace",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "880bb711d3c400cea004497bb55c0f7a",
    "title": "Intas on import alert as FDA flags data manipulation, management failures in warning letter - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQLWJaYmJ6bmdjMDU1ZHl4TVU4eWxtcFZwVUhaZnQ2M1BmOEphQ1JFRE82V2NZamFNNVNPUHBNcmZvTDFHbEJkV3NKbzJBN25PTVlaZ2N6OTFZalFmYnA5ai0tcXFnVklLWEtmVjJDRDVEa19mQ2tSMkJQbkhPbmdKME02dWEzc0tfVGVZTU5HbVotTnQzc1A3T3luNkdNbjR0LWFYVnYzUjJ1U1BBZ2s1Rw?oc=5",
    "date": "2023-11-29T08:00:00.000Z",
    "dateFormatted": "29/11/2023",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Intas on import alert as FDA flags data manipulation, management failures in warning letter  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "a2b97dc6547c33452ebd5c8fd8d70dc0",
    "title": "Untitled Letter Rexulti - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE01TkNQOFZyTXprWkVONXVtYnpiWk03TkMtMnNoUGNJZ3hxSEl6V09XTUtfczJMUFZxMFpwRHFjdFBJWnE3M3hpOVh2Nl9WZURUZjZJ?oc=5",
    "date": "2023-10-31T07:00:00.000Z",
    "dateFormatted": "31/10/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Rexulti  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "a277a723d93821c071727713e716bd5b",
    "title": "Untitled Letter Phexxi - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9TdV92Slg0Sm5rYVdQT2RUQk1VeWVQaWxpLURlQ0E4YURvSjF0YmVOQ1dnaF9DbnhSbEI2dzE3eXNRTDZaTW1iZ0xNXzBTeDNNTm40?oc=5",
    "date": "2023-10-31T07:00:00.000Z",
    "dateFormatted": "31/10/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Phexxi  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "212a55ba6c21ca7284278e0c484e7808",
    "title": "Office of Prescription Drug Promotion Untitled Letters - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPbTF2UUdtQmpZempPSVVJZlhlS1BMMmQ4ZHdCRkpVT01KOWJ4ZEpoX00ydGxLcmJTemZTZGRzRFpMQUNaY09ZZ1FHNzFNNVBjUE92ZFNwYXNVRlNuR1pXZFQway1POGhUaTFOcDY0dElHN0Rpb250TDRsM1hidThXb1JPYXB6MmxUc0dQQ2JsY0xuR2VWT09oUG5wemJIS2FJMndUZEZqcTFodXd5YkJoSHZR?oc=5",
    "date": "2023-10-25T20:05:34.000Z",
    "dateFormatted": "25/10/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Office of Prescription Drug Promotion Untitled Letters  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "e60160748eaf1f5ff171192ebeee52d8",
    "title": "Warning Letters and Notice of Violation Letters to Pharmaceutical Companies - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQOWhBYlN5dHpxRS13ZXBES2QyLXVfRk90WDBxY2pjSGFBSW5Za3JJN2pVNHJORjVRdmRWTXBGLXFpOHE3WUxjU0hzOW43V04tMjFxUWRoUjBsMk1CdWVuZzhVRVd1VHZkNkZaUW5uN0o0QkszU21KMVRLVUYwaDVFLWJzNWt2c2lTa3h2eUhJQnJ0Sy1CQzVvQ0JpQWRMR1JnRWs1QmlvalhNWXp5ZHlBMFFGVy1lTGNOb1l4RUFscw?oc=5",
    "date": "2023-10-25T07:00:00.000Z",
    "dateFormatted": "25/10/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Warning Letters and Notice of Violation Letters to Pharmaceutical Companies  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "26b149638ad29b1b1d79f2a5b495c947",
    "title": "FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOc1VHNmJUR3dFN2lEMWtTeXF5eFduR1hpclZHd21OaHJVXzNKNFhucXdIS19LYng4cDNMMl9jd0pibXpleWFDc0Y4ZHJoSE1WUTBrdUYtcUpIZ1RjUU9iX3dqbEVNRDgxYWNjVDNXaHp4dk9HZmVYSjdrQUw1aUNqS0JYdmk3TnFKal9xa0NwY1gxLTNuN0xtdVJPN0ZPbzFOTTVJZVBpMEFvcFNjVVhBU2lwQUNCanVwRUE?oc=5",
    "date": "2023-09-12T07:00:00.000Z",
    "dateFormatted": "12/09/2023",
    "source": "Google News - FDA Warning Letters",
    "sourceCategory": "google",
    "sourceType": "foia",
    "summary": "FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "22724957ec4742290f7c4dd7a18d5106",
    "title": "Untitled Letter for Slynd - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBtUmZzU3BteEN5WktDRHJSYU5YNkMwQzIzbUQyY1lUSHhfZGtERnZFMkZVNl85cXBEUWJIR3NmYXRGQXIzeE5UM3NSUlU4LXhDdnVZ?oc=5",
    "date": "2023-08-11T07:00:00.000Z",
    "dateFormatted": "11/08/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter for Slynd  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "f2a4c45ddab4a403c652a4de7d119bba",
    "title": "Untitled Letter Close-Out Recorlev - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBFNk5wOW1xS2JHYVBUTFhNWFBqOHY2el9QR2tYVUx0WWtPUGdDMUZMN3hDRWMwM2FnSXdsVktrQkU3QUNZeko5bmlfcnNWQTVWcjFR?oc=5",
    "date": "2023-08-09T07:00:00.000Z",
    "dateFormatted": "09/08/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Close-Out Recorlev  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "5a213c6e97215bd15f2a0bf23d5427d6",
    "title": "Untitled Letter Recorlev - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1JY2dLc1UwLXlWakpqZUROeVEyU3BFaG9oYkNOelZOblh0eGo2S2xGNFNnaE0xdDN3Q2Y4Sm9QZW9senl4NDZ0NDBTQk9RMGRLUFQ4?oc=5",
    "date": "2023-07-06T07:00:00.000Z",
    "dateFormatted": "06/07/2023",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Recorlev  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "e10c92ca9fa67d28d3d5650274a81194",
    "title": "Sun Pharma facility under an import alert handed a warning letter - Endpoints News",
    "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxORV8yakNTNHpLTi1La05mSEdOSFYzZkw4Q3EtUXlzcDAzdGxhTEpiRk5vbUd2WEVmYVd6N1FMdmU4RlJYT3BXdjRXTldna1k0bVphLXJObzlyTVFINldjMHI2dkFtUXdiOEJsWnNVTGxtQjlScnRaMk9HUnU4YlZOc2tnby1YWHZ6MWlwdUEwQ2lQckk?oc=5",
    "date": "2023-01-11T08:00:00.000Z",
    "dateFormatted": "11/01/2023",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Sun Pharma facility under an import alert handed a warning letter  Endpoints News",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "c949d42c2bc04aad4edbb0c9ac369b9f",
    "title": "Mexico's Glinsa suffers warning letter and import alert after refusing FDA manufacturing inspection - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPY1NQeEVCRFFGMGdOQXg4R1E4T1pzYmFucmZFZWthX2pvY2I3RTkxQktHTlNSWHRNc2pmbGpEbmVIYUxXUjNlN0tnUFkzTUZLMXRfUDFjUENlclB6Z1hsSUhOcV9fQVlPR09iOUl6d1hoY0ZTLU9HYWVJTXNFNFRUd1ZRMTZGVDdDaXN1cFZpMkVKNDNtNjdZOHBGUUFEa2htYkNBN1BzaW82R0J0eXl3QXZjRnZpdEhFX3pKSGRCbU82N3dC?oc=5",
    "date": "2022-06-23T07:00:00.000Z",
    "dateFormatted": "23/06/2022",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Mexico's Glinsa suffers warning letter and import alert after refusing FDA manufacturing inspection  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "19b43c59469eae833e0364afbac4e2ac",
    "title": "Untitled Letter Roszet - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE95R1JUMkZWRmxNU2QyalV1bkgxd1FXdEoyQWhxcGZDa05PUDVkMWp2VF9GVDZMcUZtLTJhY0gweF9tRm9iZm1pU281QUxod3ZrOFJF?oc=5",
    "date": "2022-06-02T07:00:00.000Z",
    "dateFormatted": "02/06/2022",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter Roszet  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "1324b93d0352bee7ace111c09a4602f2",
    "title": "Untitled Letter DUOBRII - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9yeUFKQVhWNzItMUZyV0lmUkhOM2s5dTVNdGxmTW5qSWM2NE9lSFB5ZVl5RUVIZGZQdkE3WjFua1dIS1daRG5XTG5EX1RzQXdYclBJ?oc=5",
    "date": "2022-03-31T07:00:00.000Z",
    "dateFormatted": "31/03/2022",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter DUOBRII  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "d2fb0d5491f560044c89d1ac57c3ebf3",
    "title": "Untitled Letter | NEULASTA® (pegfilgrastim) injection, for subcutaneous use - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9jT1pjaC1aWVJPSS1FdEQ3SU9aejhsdDJuTGlXRy1ESFBDUWhVSWVhWHdUZEZHTmdsbzRFQnRLMEdEcnp4RTdMWmljX0tlc3k3ZEI4?oc=5",
    "date": "2022-01-11T08:00:00.000Z",
    "dateFormatted": "11/01/2022",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter | NEULASTA® (pegfilgrastim) injection, for subcutaneous use  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "c54fe660dbf854db25d34fc34d6907fa",
    "title": "RESPONSE TO UNTITLED LETTER | EMGALITY - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBlbzNtdXNnZEJLaWlwNnVWVXBWSTd2TlRaa2w3eUpFbzJDazVvNzJEMlJZcmZyTHFtT09ybDVrQUJnbGRKX0kxQklzeXd3UFVrWTgw?oc=5",
    "date": "2021-12-21T08:00:00.000Z",
    "dateFormatted": "21/12/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "RESPONSE TO UNTITLED LETTER | EMGALITY  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "3cdb23b6d5391f8529eb76b84ea12c69",
    "title": "Emgality Untitled Letter - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBfN0szeDVZTG1TRXNKa2FhRTJkUFhhTnhmejFKa1Y1NjhYMzZRUnJ5TmI1NFR4MXM3UWxad0R5TW9VM2UyUU1fUW04Z0JtUFNJUlNV?oc=5",
    "date": "2021-12-13T08:00:00.000Z",
    "dateFormatted": "13/12/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Emgality Untitled Letter  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "28281e6b2c8ec9f6af31aef78136d730",
    "title": "Untitled Letter | NURTEC ODT (rimegepant) orally disintegrating tablets, for sublingual or oral use - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5DWWhZUVQ2cldOTDdFb2tKRUl1TkhrUmdteHYwYTJIdGhzRjJXMHhNUmMzZ3ZVY3laOGppYnVqZlZWdWdNR1VNaGpmazB5Q1J1V3pR?oc=5",
    "date": "2021-11-19T08:00:00.000Z",
    "dateFormatted": "19/11/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter | NURTEC ODT (rimegepant) orally disintegrating tablets, for sublingual or oral use  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "bef2b72a25f39ae028a21e14c6ad396f",
    "title": "After triggering a global valsartan recall 3 years ago, Chinese drug manufacturer overcomes FDA warning letter - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNTktObVVMQXZ2QlMwWVlVNFBPakZkSEVwTDMtaVFPalBrQVA1dDhfSHpobnVMWG1JcFRCSXJubkFFRUtQb2R6UFEtaEJXLUVodnRySENkNXVvNjAteUg0NUhldmVDN3h4NlowTm5PbmxkYTlRS0dIUmlGTjA3RU90Y0tSWEtEaGN1LWsxSHJPaXBkbHZ2WmRmZzAzd0FHaTJ5X3BXeE1XQnpQV0IxbnRlb0xIdHdLa2gwRm5vaG9uMlptZU4t?oc=5",
    "date": "2021-11-15T08:00:00.000Z",
    "dateFormatted": "15/11/2021",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "After triggering a global valsartan recall 3 years ago, Chinese drug manufacturer overcomes FDA warning letter  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter",
      "recall"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "fd7e7b688405c1492072011bc7e8e93b",
    "title": "Untitled Letter | ALKINDI® SPRINKLE (hydrocortisone) oral granules - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBtX3doR00zQVlRWGVTLS1mRXNMTDlIZWJSZ1p3RWdLS3RiU2JkLXphQjB0VFhTeWYzZEVSTlNtd29NTjJ6WExqMFpDYUFRRmlDVVdz?oc=5",
    "date": "2021-10-04T07:00:00.000Z",
    "dateFormatted": "04/10/2021",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Untitled Letter | ALKINDI® SPRINKLE (hydrocortisone) oral granules  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "83bf726a70b05960043ad3014a33fcde",
    "title": "FDA warning letters detail violations at China, Mexico drugmakers already under import alert - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPdG5panZOR0dXUjZrbUh4VjM1c01NNnB2NzNvdHZzMWdiOXVHQm5tQVdJMWlneFJTSHAxUHppQU9mSWhQNlc5SEtTOERuMGo2Y0dORmRoYXBTMl9yNGMxaGt6bm1YNVBJN2RoeEpjc2RzNlBocmJlODZrOGpnYmdNSzAxUVFvMTd4UlpFeHBMem02SGxQS2hqbEdfb1NxaTJZTmNrSWVLOA?oc=5",
    "date": "2021-03-17T07:00:00.000Z",
    "dateFormatted": "17/03/2021",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA warning letters detail violations at China, Mexico drugmakers already under import alert  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "534fd18fabb410dee844850b1b329038",
    "title": "WARNING LETTER - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBYTFRCbFBpYnp2c0JLSDhwRThuajFFZjF3Z0ZtTDl3Si1TM3k1RW9VdDhQcUQ4Q1ZYRDRyd0lqZ1JYdjZyenU0aFZpOWV5VEc2c05F?oc=5",
    "date": "2020-09-22T07:00:00.000Z",
    "dateFormatted": "22/09/2020",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "WARNING LETTER  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "86dfaa3a1de002e9c6df370558dd3b94",
    "title": "WARNING LETTER - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFA3eGJVXzVDSGxHclRKYTRqRDFqY1dVZE8wcEJTb1FIWW5QSmYybTNJam9vUjRKOUNjaVluRlRYeXlQSHBkNmVOTG94OFZJVnoyTTJF?oc=5",
    "date": "2019-08-16T07:00:00.000Z",
    "dateFormatted": "16/08/2019",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "WARNING LETTER  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "651823c32ae6096783d16fbbe5e2e752",
    "title": "An Analysis Of FDA FY2018 Drug GMP Warning Letters - Pharmaceutical Online",
    "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNQV9IQVAxQWhXZnh3ZUN3cWl0aFlWZjNIN3ZmRmNfRVExM0R6U0lWbEk5R3A4OU1sN1BrWDdYazdnLXoxb19tTmJRdWtKUENVLWNnM2JiVXJYbmRRMGV5MFFFYVhFcEVJNGNlSGhMWXZVTVBxTG9fZHVyWERxb1EzNEE3aER1VkRtdnNkbldxdU1fdTNrVGJz?oc=5",
    "date": "2019-02-01T08:00:00.000Z",
    "dateFormatted": "01/02/2019",
    "source": "Google News - Consent Decrees",
    "sourceCategory": "google",
    "sourceType": "consent_decree",
    "summary": "An Analysis Of FDA FY2018 Drug GMP Warning Letters  Pharmaceutical Online",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "eef894f12a23642f7bf3e16ff899cc9a",
    "title": "Dear Dr. Woodcock, I am writing to bring to your attention a Warning Letter that Vanda received from the FDA on October 22, whic - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE51ZFIybzZCOG0tY3oyWVZrTGpDbEhkODNncUNYYXI0dWU4bDI5TnZYMzFYQjh0eWlNNEV2Y0lGMVUzZ2JTYUVkczE5RTJjM0NGMWtB?oc=5",
    "date": "2018-10-22T07:00:00.000Z",
    "dateFormatted": "22/10/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Dear Dr. Woodcock, I am writing to bring to your attention a Warning Letter that Vanda received from the FDA on October 22, whic  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "c62d5959b93d1b6fa7304d3ef56103b0",
    "title": "WARNING LETTER - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE10aThhZ3k1N3pKUE9xd1JhazU2dUNaQmlLamxmeWFmZGZKeFZCbGFNYzVYOVJUSFAtVlV3LTI3ZThaejBfYTVMS1hrRnl5ODF0Qzkw?oc=5",
    "date": "2018-10-22T07:00:00.000Z",
    "dateFormatted": "22/10/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "WARNING LETTER  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "6b79eab66b82408c372d30a9f3844e4d",
    "title": "WARNING LETTER - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE50czRfM05aa2dzMmluM3E0ZVg3T0cyaGppcFczeEZRalVrVWEtN2RlSkJEblFmVGRrTkdjTXlLbURkMXFXcG5BUlN4WUNsMTdVTXEw?oc=5",
    "date": "2018-10-05T07:00:00.000Z",
    "dateFormatted": "05/10/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "WARNING LETTER  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "673313d00e63c33f84ead918b9196b27",
    "title": "FDA warning letter tells India's Goran Pharma to get professional help - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOcnVvdlRNOGt2dV9pa1lvS0VvT1VIQ1U2OVhXMFRUV3J6ZWJsS2RsbUdXcVo3MkNGVndBa3JCc0g5UHJrUzR0czg4TTRLRkhRbVRRSkJaN1RZVTJ2RDVvZ2JURFVRZ1NfZ0xvMDJGTjJhMkw2QnkybFNWbWN5UlhTS1hSSmstMDU2anQzQVBMYnBxYmQteEFLTWR4TndNNWd1Sk1HWDRDVlJLaW1sano2MkxHUQ?oc=5",
    "date": "2018-05-10T07:00:00.000Z",
    "dateFormatted": "10/05/2018",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA warning letter tells India's Goran Pharma to get professional help  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "f1b48f5ab8e490a7e8419d9cdefc4de1",
    "title": "FDA hits Dominican Republic drug manufacturing plant with warning letter - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxONF8yZEliV1J5b1EwNm1ISjc5YUF4VjhSTVdURFdKaDkySEZManc2Um5ic2g1R2ppU2ZTUkUtenlDWlFBemxOYWNDNDJHV0NnSTJxTm13NTZvdUhQRURleko0em9YaDdCWGU3aDNYSkdsWl9WdWJEcnBuQ3lfbWFHWHFNaUJGX0UtWjFnekNmRzg2dWN2U0dhd3hNWVVRS0JrZGZibk1CbFN5S0tmbnJj?oc=5",
    "date": "2018-04-03T07:00:00.000Z",
    "dateFormatted": "03/04/2018",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "FDA hits Dominican Republic drug manufacturing plant with warning letter  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "de2949614274bee34671d0e8f2cb171e",
    "title": "February 27, 2018 Untitled Letter - IDELVION - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPTU1UV1RVdjlHbENseVIwTXJKdnBHTEtpM1FTUWp1cUd6OVR6d2k5Xzl0RV9FM2xZdEtDT0d6SjBGdEFTbkNWUkxYYU9DdWdQRDdqdFVWamFRWDdYa3VHeWVueGdsNjZrR3RmM05aZk81ck1HOHlGbEFxTmt4UjJOR0N4dVBTSGR6TWVnOWdyU0dJbUxJdUJyRVdFSHJzSVJHamxNMS14cVp3NWRNVFA4c2h4ZEZLMVIxc0Nsb2VOdw?oc=5",
    "date": "2018-02-27T08:00:00.000Z",
    "dateFormatted": "27/02/2018",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "February 27, 2018 Untitled Letter - IDELVION  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "800f0c9c623ef23d94130e31cd49ff22",
    "title": "Lost in translation, FDA slaps Chinese drugmaker with warning letter for mixing up APIs - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPbXdmN25YWDA2MURzYkhXMFNNS2YxVWRBdkZxQzBHb19oRWxHRklyQ2lJT1NwSXFvZVM3ZWtoTmNHMjc1SUJaTGZUWl9IOHYtLVZrZW9MZ1FPQXVXWVgwMEtSSFBsVXpBODhpcl9TWG1MejA5TXBjNV9WMnMyOXYyNDlBOXVabEpMU3RQVXl3dmktM1VYYVIxank2LS1EX0tvQVJHOEhGWVR6OWRmMExKbDNNUXZJRUdvRS1KVFVn?oc=5",
    "date": "2017-11-08T08:00:00.000Z",
    "dateFormatted": "08/11/2017",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Lost in translation, FDA slaps Chinese drugmaker with warning letter for mixing up APIs  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "0ccad4270d3d4297828c546a63b2eaf9",
    "title": "South Korean drugmaker slapped with FDA warning letter, import alert - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNUFc1MzVUdUdrNk5Ud3hFMG5qTjhrdW1uMjlocWRleTZydExIU1RidmRqM21ibjFwUkh1VG5DRXNGYzF1MUh5UmhIZTZrYnBKUEEyaGFidHExZUlTVDNNdVFJWllMZnVMQlBYTEZIbWowaGw5bjJjU2RyNVZMQkJIWUItTFV5MUdTY3hrc1dYS05BRVdXRDRHbTFfcU5iTEVldHl3bzA3MkE?oc=5",
    "date": "2017-09-21T07:00:00.000Z",
    "dateFormatted": "21/09/2017",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "South Korean drugmaker slapped with FDA warning letter, import alert  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "094fd4df02593120ce3ab972cfe4c163",
    "title": "Orexigen Therapeutics, Inc. (Contrave) Untitled Letter 5/18/2017 - fda.gov",
    "link": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxPQ3JlRXQ1eG9BcWp1RG5iR0h1aW11blJvMkRGXzI1ZWJNZ2RCd1N0bTlwSVpCVHpISUVEWExwRWNpN013NFdIbk1MTWRxVDM0ODBHbGlQUjhMeU1YazFWdFk5d2FxbmZOYnM4NjhCOFU1dXJTVUJmODFfYzZtYXE4cUVvbVNQb3hYMTRiV2VTUUlMV1M4Mkx4WVItQzVJNndxd3B2NkY1TUY2NGZYNEFid2dfdFdMOHNJSnM5R28tdG5QUURHVkFYbTBiUmtWZllkRTBSZTZoODJtdEZZT2xzelZtQjNSVm9yeVE?oc=5",
    "date": "2017-05-23T07:00:00.000Z",
    "dateFormatted": "23/05/2017",
    "source": "Google News - OPDP Letters",
    "sourceCategory": "google",
    "sourceType": "opdp",
    "summary": "Orexigen Therapeutics, Inc. (Contrave) Untitled Letter 5/18/2017  fda.gov",
    "company": "TBD",
    "types": [
      "warning_letter",
      "opdp"
    ],
    "severity": 8,
    "priority": 3
  },
  {
    "id": "93bd249ad2a485d0d7ac38141cce1832",
    "title": "Import ban extended as India's Pan Pharma racks up third FDA warning letter - Fierce Pharma",
    "link": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQS0RQc0FMZm5LYmRKa1dqV1ZPbVJINmxJUGVVX0w1cWJRbFVLcXZJOF9oclcwd3pZNFRZaWFtRGxVd1ZFeGM4azFaLVNKZzFkcmpjODJ6cnVaMGc4RGpFRlRuUlZGSDRhX2k2cFk1Z2hPNndCVjNxRzR5SEg3bVI4RTRoZklNbUxDWTMxZWx6QmpLblcxUXFnclg1Z3BkVkxtR095T2ZyblJpOGs?oc=5",
    "date": "2016-09-07T07:00:00.000Z",
    "dateFormatted": "07/09/2016",
    "source": "Google News - Import Alerts",
    "sourceCategory": "google",
    "sourceType": "import_alert",
    "summary": "Import ban extended as India's Pan Pharma racks up third FDA warning letter  Fierce Pharma",
    "company": "TBD",
    "types": [
      "warning_letter",
      "import_alert"
    ],
    "severity": 8,
    "priority": 3
  }
]